13:27:07 EST Thu 26 Dec 2024
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Else Nutrition Holdings Inc
Symbol BABY
Shares Issued 179,668,121
Close 2024-11-05 C$ 0.03
Market Cap C$ 5,390,044
Recent Sedar Documents

Else Nutrition to hold Q3 2024 results call Nov. 14

2024-11-06 10:23 ET - News Release

An anonymous director reports

ELSE NUTRITION SCHEDULES THIRD QUARTER 2024 BUSINESS UPDATE CONFERENCE CALL

Else Nutrition Holdings Inc. plans to host a business update conference call at 10 a.m. ET on Nov. 14, 2024, to discuss the company's financial results for the third quarter ended Sept. 30, 2024, as well as the company's corporate progress and other developments.

The conference call will be available via telephone by dialling toll-free 1-877-704-4453 for United States callers or 1-201-389-0920 for international callers. A webcast of the call may be accessed on the company's website.

A webcast replay will be available on the company's website through Nov. 14, 2025. A telephone replay of the call will be available approximately three hours following the call, through Nov. 21, 2024, and can be accessed by dialling 1-844-512-2921 for U.S. callers or 1-412-317-6671 for international callers and entering conference ID 13750029.

Interested parties who would like to submit a question to be addressed on the call can e-mail the question to baby@crescendo-ir.com.

About Else Nutrition Holdings Inc.

Else Nutrition Holdings is a food and nutrition company in the international expansion stage focused on developing innovative, clean, and plant-based food and nutrition products for infants, toddlers, children and adults. Its revolutionary, plant-based, non-soy formula is a clean-ingredient alternative to dairy-based formulas. Since launching its Plant-Based Complete Nutrition for Toddlers, made of whole foods, almonds, buckwheat and tapioca, the brand has received thousands of powerful testimonials and reviews from parents, gained national retailer support and achieved rapid sales growth.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.